Adcetris
Market Access/ News/ News/ News/ Oncology/ Top stories
NICE backs NHS use of Takeda’s Adcetris for rare blood cancer
Phil Taylor
Adcetris, lymphoma, NHS, NICE, rare disease, Takeda
0 Comment
X
NICE backs NHS use of Takeda’s Adcetris for rare blood cancer
https://pharmaphorum.com/news/nice-backs-nhs-use-of-takedas-adcetris-for-rare-blood-cancer/
Cancer/ News/ Pharma Market Access/ UK & Europe
Adcetris falls victim to NICE’s Cancer Drugs Fund clear-out
Andrew McConaghie
Adcetris, cancer, CDF, NHS, Oncology, Takeda
0 Comment
More CDF legacy products likely to face same fate
X
Adcetris falls victim to NICE’s Cancer Drugs Fund clear-out
https://pharmaphorum.com/news/adcetris-falls-victim-nices-cancer-drugs-fund-clear/